EP3466939 - Bibliographic data
NOUVELLE FORME CRISTALLINE DE LA DAPAGLIFLOZINE, SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION
| Last update | 16/07/2025 |
|---|---|
| Legal status | Brevet déchu |
| Origin | Euro-PCT |
| (73) Holder |
Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Economic and Technological Development Zone
Lianyungang, Jiangsu 222047
Chine
|
|---|---|
| (72) Inventors |
Xiang LI Economic and Technological Development Zone
Lianyungang
Jiangsu 222047
Chine
Lei HE Economic and Technological Development Zone
Lianyungang
Jiangsu 222047
Chine
Jun YU Economic and Technological Development Zone
Lianyungang
Jiangsu 222047
Chine
Jinjia WANG Economic and Technological Development Zone
Lianyungang
Jiangsu 222047
Chine
Zuyin DU Economic and Technological Development Zone
Lianyungang
Jiangsu 222047
Chine
|
| (74) Agent |
Mail recipient EP&C P.O. Box 3241
2280 GE Rijswijk
Pays-Bas
|
| (21) Request number | EP17802110.1 |
|---|---|
| (22) Request date | 22/05/2017 |
| (11) Publication number | EP3466939 |
|---|---|
| Publication date | 24/02/2021 |
| (54) Title of the invention | NOUVELLE FORME CRISTALLINE DE LA DAPAGLIFLOZINE, SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION |
|---|---|
| (51) International classification | C07D 309/10, A61K 31/351, A61P 3/10 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 201610347924 |
|---|---|
| Initial application | None |
| Divisional application | None |
| Expected annuity |
Annuity: 5 -
Amount: 90 € -
Due date 31/05/2021
Surtax: 5 - Amount: 18 € - Due date 01/12/2021 |
|---|---|
| Last annuity | None |
| Publication | None |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 24/02/2021 Entrée en période de grâce du brevet d'invention - Legal date 01/06/2021 Déchéance du brevet d'invention après période de grâce - Legal date 31/05/2021 |